Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
World-first Approval For Multiple Myeloma Drug APLIDIN(R) 2018-12-11 15:10
GenEdit Closes $8.5 million Series Seed Financing 2018-12-11 13:17
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 09:47
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services 2018-12-10 16:00
CStone Pharmaceuticals Appoints Former MSD Global Oncology Early Development Executive Director Archie Tse, M.D., Ph.D., as the newly established SVP, Chief Translation Medicine Officer 2018-12-10 15:38
Concord Medical Schedules 2018 Annual Meeting of Shareholders 2018-12-07 17:00
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
Panther Orthopedics Announces Successful Clinical Use of the PUMA System (TM) 2018-12-05 15:00
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018 2018-12-04 20:00
AGC Enters Agreement to Acquire Synthetic Pharmaceutical Active Ingredient-manufacturing Plant in Spain 2018-12-04 14:00
Huiyihuiying's Full-Cycle Medical AI Products Makes Their Debut at RSNA 2018 2018-11-30 21:00
China's online healthcare platform jianke.com upgrades its Jianke Doctor brand and enters into strategic cooperation with Pfizer 2018-11-29 19:29
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs 2018-11-29 15:40
YITU releases the world's first AI-based cancer screening solutions at the 2018 RSNA Annual Meeting 2018-11-29 14:48
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies 2018-11-28 19:44
Health Care Originals Announces Strategic Alliance With Healthport For Australia And New Zealand 2018-11-28 15:00
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan 2018-11-28 08:00
Spring Pharmaceutical Group Inc. Starts Harvesting Seed Pods from Its Acer Truncatum Bunge Planting Bases 2018-11-27 20:00
AirXpanders Announces 4,000th AeroForm Implant 2018-11-27 06:11
Foresee Pharmaceuticals Announces Completion of Last Patient Visit in Registration Phase 3 Study of LMIS 25 mg (fp-001) for the Treatment of Advanced Prostate Cancer 2018-11-26 21:30
1 230 231 232 233 234 431